PTX3 and atherosclerosis: In addition, pentraxin-3 affects the lipid metabolism in human macrophages by stimulating the uptake of oxLDL and inhibiting cholesterol efflux [48], thereby contributing to the initial stages of EC dysfunction and consequent atherosclerosis.